Abarelix
阿巴瑞克
Report date: 2022/01/14 13:23:58
NME
Base Information
Drug NameAbarelix
Drug Alias Name +[10]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2003/11/25
Country/Territory
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesPraecis Pharmaceuticals IncSpeciality European Pharma LtdContura Ltd
Active IndicationsN/A
Inactive Indications